Skip to main content
OpenTrials
Completed

NCT Number: NCT03936673

Effect of Nephrostomy on Relative Function of Obstructed Kidney

Urinary tract obstruction is a serious health problem due to kidney damage. Relative renal function has an important role in the treatment of obstructed kidneys. Nephrectomy can be recommended when the relative renal function is 10% or less in radionuclide examinations. Recently, however, nephron sparing approaches have come to the fore. This indicated the need to evaluate the possibility of recovering the function of the kidney before nephrectomy. The aim of this study is to compare relative functions of obstructed kidneys in technetium 99m dimercaptosuccinic acid scintigraphy (DMSA) before and 2 weeks after nephrostomy tube.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Urology, Ercieys University, Faculty Of Medicine,

Kayseri, 38039, Turkey (Türkiye)

About this study

Obstructive uropathy is one of the most important causes of acute renal injury and end-stage renal failure. obstruction of urine flow increases the intratubular pressure. This pressure increase causes decrease in renal blood flow and starts the inflammatory process. In the first few hours after total ureter obstruction, due to the increase in intratubular pressure glomerular filtration ceases and tubular transport is markedly decreased. Long lasting obstruction results in renal fibrosis and end stage renal damage. Basically obstructive uropathy leading to irreversible renal damage and loss of renal function is the main indication for simple nephrectomy. Serious renal parenchymal damage is defined as non-functioning kidney having relative renal function (RRF) 10% or less in the literature. But recently in some studies it was suggested that by applying the nephrostomy catheter, ability of kidney to regain function can be evaluated before nephrectomy. So, possibility of gaining function should be kept in mind. In this study effect of percutaneous nephrostomy tube on serum creatinine, blood urea nitrogen (BUN) and RRF in obstructed kidney with RRF 10% or less. Before and 2 weeks after percutaneous nephrostomy, serum creatinine, ure and RRF in DMSA was recorded and compared.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Unilateral obstructed kidney with RRF 10% or less
  • Unilateral obstructed kidney with grade 2 or more hydroureteronephrosis
  • Defined etiology for unilateral obstructed kidney
  • estimated glomerular filtration rate (GFR) ≥ 30ml/min
  • Approving the nephrostomy procedure

Exclusion criteria

  • Unilateral obstructed kidney with RRF above 10%
  • Estimated GFR <30 ml/min
  • diagnosis of bilateral obstructed kidneys
  • not approving nephrostomy

Treatment and study plan

Percutaneous nephrostomy

Procedure

Primary outcomes

  1. serum creatinine level 2 weeks after nephrostomy

    Time frame: 2 weeks after nephrostomy

    serum creatinine level 2 weeks after nephrostomy

  2. Serum BUN level 2 weeks after nephrostomy

    Time frame: 2 weeks after nephrostomy

    Serum BUN level 2 weeks after nephrostomy

  3. RRF in DMSA 2 weeks after nephrostomy

    Time frame: 2 weeks after nephrostomy

    RRF in DMSA 2 weeks after nephrostomy

Sponsors and collaborators

Lead sponsor

TC Erciyes University

Other

Registry information

Official study title

The Effect of Percutaneous Nephrostomy Application on Obstructed Kidneys With Relative Function of 10% or Less In Technetium-99m Dimercaptosuccinic Acid (DMSA) Scintigraphy

Important dates

Study start
2014
Primary completion
2018
Study completion
2019
First posted
May 3, 2019
Registry last updated
May 3, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.